Jones Day advised Nuvalent on the deal. Nuvalent, Inc. announced the establishment and prosecution of global patent portfolios related to small molecule ROS1-selective inhibitors, ALK-selective inhibitors, and...
Jones Day advised Nuvalent on the deal. Nuvalent, Inc. announced the establishment and prosecution of global patent portfolios related to small molecule ROS1-selective inhibitors, ALK-selective inhibitors, and...